BriaCell Therapeutics Corp. (BCTX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 14.05M |
| Enterprise Value | -374,136 |
| P/E Ratio | -0.25 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.91 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.04 |
| Fiscal Year | July 31, 2025 |
| Most Recent Quarter | April 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.13 |
| Return On Equity | -1.48 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -147,888 |
| EBITDA | -37.58M |
| Net Income | -36.49M |
| Diluted EPS | -62.6 |
| Total Cash | 22.8M |
| Total Cash/Share | 3.15 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 7.07 |
| Book Value Per Share | 3.23 |
| 52-Week Change | -89.55 |
| 52-Week High | 31.6 |
| 52-Week Low | 2.6 |
| Moving Average 50 Days | 3.68 |
| Moving Average 200 Days | 6.7 |
| Average Volume | 204,195 |
| Shares Outstanding | 1.88M |
| % Held by Institutions | 13.8 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | August 25, 2025 |